Teladoc Health (TDOC) to Release Quarterly Earnings on Tuesday

Teladoc Health (NYSE:TDOC - Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Tuesday, February 18th. Analysts expect Teladoc Health to post earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Investors that wish to listen to the company's conference call can do so using this link.

Teladoc Health Stock Up 5.5 %

Teladoc Health stock traded up $0.72 during midday trading on Wednesday, hitting $13.83. 26,356,294 shares of the stock were exchanged, compared to its average volume of 7,325,787. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a 50 day moving average price of $10.41 and a two-hundred day moving average price of $9.35. The firm has a market cap of $2.38 billion, a P/E ratio of -2.40 and a beta of 1.05. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $20.88.

Insider Transactions at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.95% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Royal Bank of Canada boosted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Oppenheimer reduced their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research note on Friday, January 24th. Piper Sandler restated an "overweight" rating and issued a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. TD Cowen reduced their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, October 31st. Finally, Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $12.18.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.